Inhibrx Biosciences, Inc. (INBX)
NASDAQ: INBX · Real-Time Price · USD
15.55
-0.25 (-1.58%)
Nov 4, 2024, 4:00 PM EST - Market closed
Inhibrx Biosciences Employees
As of December 31, 2023, Inhibrx Biosciences had 172 total employees, including 166 full-time and 6 part-time employees.
Employees
172
Change
n/a
Growth
n/a
Revenue / Employee
$9,808
Profits / Employee
$10,001,773
Market Cap
225.10M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 172 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| ModivCare | 21,200 |
| High Tide | 1,550 |
| 2seventy bio | 274 |
| Molecular Partners AG | 168 |
| Nkarta | 150 |
| Enanta Pharmaceuticals | 145 |
| Nektar Therapeutics | 137 |
| XBiotech | 82 |
INBX News
- 7 hours ago - Inhibrx Prevails in Trade Secret Case, Reaffirming Its Commitment to Integrity and Innovation - PRNewsWire
- 2 months ago - Over $7M Bet On This Health Care Stock? Check Out These 3 Stocks Executives Are Buying - Benzinga
- 2 months ago - Inhibrx Biosciences Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights - PRNewsWire
- 5 months ago - Inhibrx: Continued Advancement Even After INBRX-101 Sale To Sanofi - Seeking Alpha
- 5 months ago - Top 4 Health Care Stocks That Are Preparing To Pump This Month - Inhibrx Biosciences (NASDAQ:INBX) - Benzinga
- 5 months ago - Inhibrx Inc. Stockholders Approve Sale of INBRX-101 to Sanofi - PRNewsWire
- 6 months ago - Inhibrx, Inc. Announces Updated When-Issued Trading Date for Anticipated Spin-Off - PRNewsWire
- 6 months ago - INHIBRX INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Inhibrx, Inc. - INBX - Business Wire